{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:34:02Z","timestamp":1788449642012,"version":"build-2803163510"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s11886-024-02040-7","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T07:02:38Z","timestamp":1710399758000},"page":"313-323","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Atrial Fibrillation Complicating Acute Myocardial Infarction: Prevalence, Impact, and Management Considerations"],"prefix":"10.1007","volume":"26","author":[{"given":"Besher","family":"Sadat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haider","family":"Al Taii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhie","family":"Sabayon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3325-8928","authenticated-orcid":false,"given":"Chockalingam A.","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"issue":"9","key":"2040_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41569-023-00857-3","volume":"20","author":"TC Frederiksen","year":"2023","unstructured":"Frederiksen TC, Dahm CC, Preis SR, Lin H, Trinquart L, Benjamin EJ, Kornej J. The bidirectional association between atrial fibrillation and myocardial infarction. Nat Rev Cardiol. 2023;20(9):631\u201344. https:\/\/doi.org\/10.1038\/s41569-023-00857-3. This study showed the risk of incident AF was higher in patients with MI vs no MI. The risk of incident MI was higher in patients with AF vs no AF. Coexisting AF and MI was associated with higher mortality compared to only MI or AF.","journal-title":"Nat Rev Cardiol"},{"issue":"15","key":"2040_CR2","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1161\/CIRCULATIONAHA.110.986661","volume":"123","author":"P Jabre","year":"2011","unstructured":"Jabre P, Roger VL, Murad MH, Chamberlain AM, Prokop L, Adnet F, Jouven X. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis. Circulation. 2011;123(15):1587\u201393. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.986661.","journal-title":"Circulation"},{"issue":"5","key":"2040_CR3","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11886-012-0289-3","volume":"14","author":"F Angeli","year":"2012","unstructured":"Angeli F, Reboldi G, Garofoli M, Ramundo E, Poltronieri C, Mazzotta G, Verdecchia P. Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis. Curr Cardiol Rep. 2012;14(5):601\u201310. https:\/\/doi.org\/10.1007\/s11886-012-0289-3.","journal-title":"Curr Cardiol Rep"},{"issue":"2","key":"2040_CR4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.120.002963","volume":"14","author":"L Lind","year":"2021","unstructured":"Lind L, Sundstr\u00f6m J, \u00c4rnl\u00f6v J, Ingelsson M, Henry A, Lumbers RT, Lampa E. Life-time covariation of major cardiovascular diseases: A 40-year longitudinal study and genetic studies. Circulation Genomic and Precision Medicine. 2021;14(2): e002963. https:\/\/doi.org\/10.1161\/CIRCGEN.120.002963.","journal-title":"Circulation Genomic and Precision Medicine"},{"issue":"6","key":"2040_CR5","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1177\/0003319720908760","volume":"71","author":"M Axelrod","year":"2020","unstructured":"Axelrod M, Gilutz H, Plakht Y, Greenberg D, Novack L. Early atrial fibrillation during acute myocardial infarction may not be an indication for long-term anticoagulation. Angiology. 2020;71(6):559\u201366. https:\/\/doi.org\/10.1177\/0003319720908760.","journal-title":"Angiology"},{"issue":"8","key":"2040_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/clc.20603","volume":"32","author":"MR Asanin","year":"2009","unstructured":"Asanin MR, Vasiljevic ZM, Matic MD, Mrdovic IB, Perunicic JP, Matic DP, Ostojic MC. The long-term risk of stroke in patients with acute myocardial infarction complicated with new-onset atrial fibrillation. Clin Cardiol. 2009;32(8):467\u201370. https:\/\/doi.org\/10.1002\/clc.20603.","journal-title":"Clin Cardiol"},{"issue":"6","key":"2040_CR7","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jjcc.2022.02.007","volume":"79","author":"H Mori","year":"2022","unstructured":"Mori H, Fukui K, Maeda A, Akashi Y, Ako J, Ikari Y, Suzuki H. Impact of atrial fibrillation and the clinical outcomes in patients with acute myocardial infarction from the K-ACTIVE registry. J Cardiol. 2022;79(6):768\u201375. https:\/\/doi.org\/10.1016\/j.jjcc.2022.02.007.","journal-title":"J Cardiol"},{"issue":"2","key":"2040_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/2048872618769057","volume":"8","author":"U Zeymer","year":"2019","unstructured":"Zeymer U, Annemans L, Danchin N, Pocock S, Newsome S, Van de Werf F, Bueno H. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry. Eur Heart J Acute Cardiovasc Care. 2019;8(2):121\u20139. https:\/\/doi.org\/10.1177\/2048872618769057.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2040_CR9","doi-asserted-by":"publisher","unstructured":"\u2022 Obayashi Y, Shiomi H, Morimoto T, Tamaki Y, Inoko M, Yamamoto K, \u2026 CREDO-Kyoto AMI Registry Wave-2 Investigators. Newly diagnosed atrial fibrillation in acute myocardial infarction. J Am Heart Assoc.\u00a02021;10(18):e021417. https:\/\/doi.org\/10.1161\/JAHA.121.021417.\u00a0This study showed newly diagnosed AF increased risk of mortality, HF hospitalization, and major bleeding higher than no AF and comparable to prior AF.","DOI":"10.1161\/JAHA.121.021417"},{"key":"2040_CR10","doi-asserted-by":"publisher","unstructured":"Dai Y, On behalf of the CAMI Registry study group, Yang J, Gao Z, Xu H, Sun Y, \u2026 Yang Y. Atrial fibrillation in patients hospitalized with acute myocardial infarction: analysis of the china acute myocardial infarction (CAMI) registry. BMC Cardiovasc Disord.\u00a02017;17(1). https:\/\/doi.org\/10.1186\/s12872-016-0442-9","DOI":"10.1186\/s12872-016-0442-9"},{"key":"2040_CR11","doi-asserted-by":"publisher","unstructured":"Luo J, Xu S, Li H, Li Z, Liu B, Qin X, \u2026 Wei Y. Long-term impact of new-onset atrial fibrillation complicating acute myocardial infarction on heart failure. ESC Heart Failure\u00a02020;7(5):2762\u20132772. https:\/\/doi.org\/10.1002\/ehf2.12872","DOI":"10.1002\/ehf2.12872"},{"key":"2040_CR12","doi-asserted-by":"publisher","unstructured":"McIntyre WF, Um KJ, Cheung CC, Belley-C\u00f4t\u00e9 EP, Dingwall O, Devereaux PJ, \u2026 Healey JS.\u00a0 Atrial fibrillation detected initially during acute medical illness: A systematic review. Eur Heart J Acute Cardiovasc Care\u00a02019;8(2):130\u2013141. \nhttps:\/\/doi.org\/10.1177\/2048872618799748.","DOI":"10.1177\/2048872618799748"},{"key":"2040_CR13","doi-asserted-by":"publisher","unstructured":"McIntyre WF, Vadakken ME, Rai AS, Thach T, Syed W, Um KJ, \u2026 Belley-C\u00f4t\u00e9 EP. Incidence and recurrence of new-onset atrial fibrillation detected during hospitalization for non-cardiac surgery: a systematic review and meta-analysis. Journal Canadien d\u2019anesthesie [Can J Anaesth].\u00a02021;68(7):1045\u20131056.\u00a0https:\/\/doi.org\/10.1007\/s12630-021-01944-0.","DOI":"10.1007\/s12630-021-01944-0"},{"key":"2040_CR14","doi-asserted-by":"publisher","unstructured":"Obayashi Y, Shiomi H, Morimoto T, Tamaki Y, Inoko M, Yamamoto K, \u2026 CREDO-Kyoto AMI Registry Wave-2 Investigators. Newly diagnosed atrial fibrillation in acute myocardial infarction. J Am Heart Associ.\u00a02021;10(18):e021417.\u00a0https:\/\/doi.org\/10.1161\/JAHA.121.021417.","DOI":"10.1161\/JAHA.121.021417"},{"key":"2040_CR15","doi-asserted-by":"publisher","unstructured":"Jons, C., Jacobsen, U. G., Joergensen, R. M., Olsen, N. T., Dixen, U., Johannessen, A., \u2026 Cardiac Arrhythmias and Risk Stratification after Acute Myocardial Infarction (CARISMA) Study Group. The incidence and prognostic significance of new-onset atrial fibrillation in patients with acute myocardial infarction and left ventricular systolic dysfunction: a CARISMA substudy. Heart Rhythm: Official J Heart Rhythm Soc. 2011;8(3):342\u20138. https:\/\/doi.org\/10.1016\/j.hrthm.2010.09.090.","DOI":"10.1016\/j.hrthm.2010.09.090"},{"issue":"9","key":"2040_CR16","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00392-021-01805-2","volume":"110","author":"L Fauchier","year":"2021","unstructured":"Fauchier L, Bisson A, Bodin A, Herbert J, Angoulvant D, Danchin N, Cottin Y. Outcomes in patients with acute myocardial infarction and new atrial fibrillation: a nationwide analysis. Clinical Research in Cardiology: Official Journal of the German Cardiac Society. 2021;110(9):1431\u20138. https:\/\/doi.org\/10.1007\/s00392-021-01805-2.","journal-title":"Clinical Research in Cardiology: Official Journal of the German Cardiac Society"},{"key":"2040_CR17","doi-asserted-by":"publisher","unstructured":"Luo J, Liu B, Li H, Xu S, Gong M, Li Z, \u2026 We, Y. Prognostic impact of the symptom of New-onset atrial fibrillation in acute myocardial infarction: Insights from the NOAFCAMI-SH registry. Frontiers in Cardiovascular Medicine 2021;8:677695. \nhttps:\/\/doi.org\/10.3389\/fcvm.2021.677695.","DOI":"10.3389\/fcvm.2021.677695"},{"key":"2040_CR18","doi-asserted-by":"publisher","unstructured":"Frederiksen, T. C., Trinquart, L., Lin, H., Dahm, C. C., Christiansen, M. K., Jensen, H. K., \u2026 Kornej, J. (). Po-05\u2013167 The bidirectional association between atrial fibrillation and myocardial infarction in the Framingham heart study. Heart Rhythm: Official J Heart Rhythm Soc. 2023;20(5):S661\u2013S662. \nhttps:\/\/doi.org\/10.1016\/j.hrthm.2023.03.1381.","DOI":"10.1016\/j.hrthm.2023.03.1381"},{"key":"2040_CR19","doi-asserted-by":"publisher","unstructured":"Romanov A, Martinek M, P\u00fcrerfellner H, et al. Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: results of the ARREST study [published correction appears in Europace. 2017 May 1;19(5):811]. Europace. 2018;20(2):263\u2013270. https:\/\/doi.org\/10.1093\/europace\/euw344","DOI":"10.1093\/europace\/euw344"},{"key":"2040_CR20","doi-asserted-by":"publisher","unstructured":"Bauer A, Sappler N, von St\u00fclpnagel L, Klemm M, Schreinlechner M, Wenner F, \u2026 SMART-MI-DZHK9 investigators. Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial.\u00a0Lancet Digital Health.\u00a02022;4(2):e105\u2013e116. https:\/\/doi.org\/10.1016\/S2589-7500(21)00253-3","DOI":"10.1016\/S2589-7500(21)00253-3"},{"issue":"13","key":"2040_CR21","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1161\/CIRCULATIONAHA.109.902148","volume":"122","author":"Bloch Thomsen, P. E., Jons, C., Raatikainen, M. J. P., Moerch Joergensen, R., Hartikainen, J., Virtanen, V., \u2026 Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) Study Group","year":"2010","unstructured":"Bloch Thomsen, P. E., Jons, C., Raatikainen, M. J. P., Moerch Joergensen, R., Hartikainen, J., Virtanen, V., \u2026 Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) Study Group. Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study. Circulation. 2010;122(13):1258\u201364. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.902148.","journal-title":"Circulation"},{"issue":"1","key":"2040_CR22","doi-asserted-by":"publisher","first-page":"551","DOI":"10.4022\/jafib.551","volume":"5","author":"JC Rubenstein","year":"2012","unstructured":"Rubenstein JC, Cinquegrani MP, Wright J. Atrial fibrillation in acute coronary syndrome. J Atri Fibrillation. 2012;5(1):551. https:\/\/doi.org\/10.4022\/jafib.551.","journal-title":"J Atri Fibrillation"},{"issue":"21","key":"2040_CR23","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/j.jacc.2008.01.055","volume":"51","author":"EI Skalidis","year":"2008","unstructured":"Skalidis EI, Hamilos MI, Karalis IK, Chlouverakis G, Kochiadakis GE, Vardas PE. Isolated atrial microvascular dysfunction in patients with lone recurrent atrial fibrillation. J Am Coll Cardiol. 2008;51(21):2053\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2008.01.055.","journal-title":"J Am Coll Cardiol"},{"key":"2040_CR24","doi-asserted-by":"publisher","unstructured":"Sagnard A, Guenancia C, Mouhat B, Maza M, Fichot M, Moreau D, \u2026 Zeller M. Involvement of autonomic nervous system in new-onset atrial fibrillation during acute myocardial infarction. JClin Med.\u00a02020;9(5):1481.\u00a0https:\/\/doi.org\/10.3390\/jcm9051481.","DOI":"10.3390\/jcm9051481"},{"key":"2040_CR25","doi-asserted-by":"publisher","unstructured":"Karaba\u011f Y, Rencuzogullari I, \u00c7a\u011fda\u015f M, Karakoyun S, Yesin M, Uluganyan M, \u2026 Tanbo\u011fa H\u0130.\u00a0 Association between BNP levels and new-onset atrial fibrillation. Herz.\u00a02018;43(6):548\u2013554.\u00a0https:\/\/doi.org\/10.1007\/s00059-017-4598-6.","DOI":"10.1007\/s00059-017-4598-6"},{"key":"2040_CR26","doi-asserted-by":"publisher","unstructured":"Parashar S, Kella D, Reid KJ, Spertus JA, Tang F, Langberg J, \u2026 Lloyd MS. New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the TRIUMPH registry). Am J Cardiol.\u00a02013;112(9):1390\u20131395.\u00a0https:\/\/doi.org\/10.1016\/j.amjcard.2013.07.006.","DOI":"10.1016\/j.amjcard.2013.07.006"},{"key":"2040_CR27","doi-asserted-by":"publisher","unstructured":"Corban MT, Godo S, Burczak DR, Noseworthy PA, Toya T, Lewis BR, \u2026 Lerman A. Coronary endothelial dysfunction is associated with increased risk of incident atrial fibrillation. J Am Heart Assoc.\u00a02020;9(8):e014850.\u00a0https:\/\/doi.org\/10.1161\/JAHA.119.014850.","DOI":"10.1161\/JAHA.119.014850"},{"key":"2040_CR28","doi-asserted-by":"publisher","unstructured":"D\u00edez-Delhoyo F, Guti\u00e9rrez-Iba\u00f1es E, Sanz-Ruiz R, V\u00e1zquez-\u00c1lvarez ME, Gonz\u00e1lez Sald\u00edvar H, Rivera Ju\u00e1rez A, \u2026 Fern\u00e1ndez-Avil\u00e9s F. Prevalence of microvascular and endothelial dysfunction in the nonculprit territory in patients with acute myocardial infarction. Circ Cardiovasc Interv.\u00a02019;12(2):e007257.\u00a0https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.118.007257.","DOI":"10.1161\/CIRCINTERVENTIONS.118.007257"},{"key":"2040_CR29","doi-asserted-by":"publisher","unstructured":"Aronson D, Mutlak D, Bahouth F, Bishara R, Hammerman H, Lessick J, \u2026 Agmon Y. Restrictive left ventricular filling pattern and risk of new-onset atrial fibrillation after acute myocardial infarction.\u00a0Am J Cardiol.\u00a02011;107(12):1738\u20131743.\u00a0https:\/\/doi.org\/10.1016\/j.amjcard.2011.02.334.","DOI":"10.1016\/j.amjcard.2011.02.334"},{"issue":"6","key":"2040_CR30","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.amjcard.2004.11.032","volume":"95","author":"SN Psychari","year":"2005","unstructured":"Psychari SN, Apostolou TS, Sinos L, Hamodraka E, Liakos G, Kremastinos DT. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol. 2005;95(6):764\u20137.\u00a0https:\/\/doi.org\/10.1016\/j.amjcard.2004.11.032.","journal-title":"Am J Cardiol"},{"key":"2040_CR31","doi-asserted-by":"publisher","unstructured":"Stacy, M. R., Lin, B. A., Thorn, S. L., Lobb, D. C., Maxfield, M. W., Novack, C., \u2026 Spinale, F. G. (2022). Regional heterogeneity in determinants of atrial matrix remodeling and association with atrial fibrillation vulnerability postmyocardial infarction. Heart Rhythm: The Official J Heart Rhythm Soc.\u00a02022;19(5):847\u2013855.\u00a0https:\/\/doi.org\/10.1016\/j.hrthm.2022.01.022.","DOI":"10.1016\/j.hrthm.2022.01.022"},{"issue":"14","key":"2040_CR32","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.4103\/0366-6999.160565","volume":"128","author":"E-Y Zhang","year":"2015","unstructured":"Zhang E-Y, Cui L, Li Z-Y, Liu T, Li G-P. High Killips class as a predictor of new-onset atrial fibrillation following acute myocardial infarction: Systematic review and meta-analysis. Chin Med J. 2015;128(14):1964\u20138. https:\/\/doi.org\/10.4103\/0366-6999.160565.","journal-title":"Chin Med J"},{"key":"2040_CR33","doi-asserted-by":"publisher","unstructured":"Li Y.-G, Bisson A, Bodin A, Herbert J, Grammatico-Guillon L, Joung B, \u2026 Fauchier L. C2 HEST score and prediction of incident atrial fibrillation in poststroke patients: A French nationwide study. J Am Heart Assoc.\u00a02019;8(13):e012546.\u00a0https:\/\/doi.org\/10.1161\/JAHA.119.012546.","DOI":"10.1161\/JAHA.119.012546"},{"key":"2040_CR34","doi-asserted-by":"publisher","unstructured":"Li Y-G, Pastori D, Farcomeni A, Yang P-S, Jang E, Joung B, \u2026 Lip GYH. A simple clinical risk score (C2HEST) for predicting incident atrial fibrillation in Asian subjects: Derivation in 471,446 Chinese subjects, with internal validation and external application in 451,199 Korean subjects. Chest.\u00a02019;155(3):510\u2013518.\u00a0https:\/\/doi.org\/10.1016\/j.chest.2018.09.011.","DOI":"10.1016\/j.chest.2018.09.011"},{"issue":"3","key":"2040_CR35","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ijcard.2014.03.010","volume":"173","author":"AC Ruwald","year":"2014","unstructured":"Ruwald AC, Gang U, Thomsen PEB, J\u00f8rgensen RM, Ruwald MH, Huikuri HV, Jons C. The predictive value of CHADS2 risk score in post myocardial infarction arrhythmias - a Cardiac Arrhythmias and RIsk Stratification after Myocardial infArction (CARISMA) substudy. Int J Cardiol. 2014;173(3):441\u20136. https:\/\/doi.org\/10.1016\/j.ijcard.2014.03.010.","journal-title":"Int J Cardiol"},{"key":"2040_CR36","doi-asserted-by":"publisher","unstructured":"Biccir\u00e8 FG, Tanzilli G, Prati F, Sammartini E, Gelfusa M, Celeski M, \u2026 Pastori D. Prediction of new onset atrial fibrillation in patients with acute coronary syndrome undergoing percutaneous coronary intervention using the C2HEST and mC2HEST scores: A report from the multicenter REALE-ACS registry. Int J Cardiol.\u00a02023;386:45\u201349. https:\/\/doi.org\/10.1016\/j.ijcard.2023.05.023.\u00a0This study showed the C2HEST score may be a valuable tool to identify ACS patients who are at higher risk of new onset atrial fibrillation.","DOI":"10.1016\/j.ijcard.2023.05.023"},{"key":"2040_CR37","doi-asserted-by":"publisher","unstructured":"Asanin M, Stankovic S, Mrdovic I, Matic D, Savic L, Majkic-Singh N, \u2026 Vasiljevic Z. B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Peptides.\u00a02012;35(1):74\u201377.\u00a0https:\/\/doi.org\/10.1016\/j.peptides.2012.02.022.","DOI":"10.1016\/j.peptides.2012.02.022"},{"issue":"1","key":"2040_CR38","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12872-022-02989-9","volume":"22","author":"J Wang","year":"2022","unstructured":"Wang J, Hu S, Liang C, Ling Y. The association between systemic inflammatory response index and new-onset atrial fibrillation in patients with ST-elevated myocardial infarction treated with percutaneous coronary intervention. BMC Cardiovasc Disord. 2022;22(1):525. https:\/\/doi.org\/10.1186\/s12872-022-02989-9.","journal-title":"BMC Cardiovasc Disord"},{"key":"2040_CR39","doi-asserted-by":"publisher","first-page":"838761","DOI":"10.3389\/fcvm.2022.838761","volume":"9","author":"Y Ling","year":"2022","unstructured":"Ling Y, Fu C, Fan Q, Liu J, Jiang L, Tang S. Triglyceride-glucose index and new-onset atrial fibrillation in ST-segment elevation myocardial infarction patients after percutaneous coronary intervention. Front Cardiovasc Med. 2022;9:838761.\u00a0https:\/\/doi.org\/10.3389\/fcvm.2022.838761.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"2040_CR40","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/echo.15574","volume":"40","author":"D Lancini","year":"2023","unstructured":"Lancini D, Prasad A, Thomas L, Atherton J, Martin P, Prasad S. Predicting new onset atrial fibrillation post acute myocardial infarction: Echocardiographic assessment of left atrial size. Echocardiography. 2023;40(6):456\u20133. https:\/\/doi.org\/10.1111\/echo.15574.","journal-title":"Echocardiography."},{"key":"2040_CR41","doi-asserted-by":"publisher","unstructured":"Reinstadler SJ, Stiermaier T, Eitel C, Fuernau G, Saad M, P\u00f6ss J, \u2026 Eitel I. Impact of atrial fibrillation during ST-segment-elevation myocardial infarction on infarct characteristics and prognosis. Circ Cardiovasc Imaging.\u00a02018;11(2):e006955. https:\/\/doi.org\/10.1161\/CIRCIMAGING.117.006955.","DOI":"10.1161\/CIRCIMAGING.117.006955"},{"issue":"9","key":"2040_CR42","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1177\/0003319719854242","volume":"70","author":"E Yildirim","year":"2019","unstructured":"Yildirim E, Ermis E, Allahverdiyev S, Ucar H, Cengiz M. Value of syntax score II in prediction of new-onset atrial fibrillation in patients with NSTE-ACS undergoing percutaneous coronary intervention. Angiology. 2019;70(9):860\u20136. https:\/\/doi.org\/10.1177\/0003319719854242.","journal-title":"Angiology"},{"issue":"3","key":"2040_CR43","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1093\/europace\/euac242","volume":"25","author":"AF Thomsen","year":"2023","unstructured":"Thomsen AF, J\u00f8ns C, Jabbari R, Jacobsen MR, Stampe NK, Butt JH, ... Jacobsen PK. Long-term risk of new-onset arrhythmia in ST-segment elevation myocardial infarction according to revascularization status. EP Europace. 2023;25(3):931\u20139. https:\/\/doi.org\/10.1093\/europace\/euac242.","journal-title":"EP Europace"},{"key":"2040_CR44","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1002\/ehf2.12872","volume":"7","author":"J Luo","year":"2020","unstructured":"Luo J, Xu S, Li H, Li Z, Liu B, Qin X, Gong M, Shi B, Wei Y. Long-term impact of new-onset atrial fibrillation complicating acute myocardial infarction on heart failure. ESC Heart Failure. 2020;7:2762\u201372. https:\/\/doi.org\/10.1002\/ehf2.12872.","journal-title":"ESC Heart Failure"},{"issue":"12","key":"2040_CR45","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1093\/europace\/euy168","volume":"20","author":"C Guenancia","year":"2018","unstructured":"Guenancia C, Toucas C, Fauchier L, Stamboul K, Garnier F, Mouhat B, ... Cottin Y. High rate of recurrence at long-term follow-up after new-onset atrial fibrillation during acute myocardial infarction. EP Europace. 2018;20(12):e179\u201388. https:\/\/doi.org\/10.1093\/europace\/euy168.","journal-title":"EP Europace."},{"key":"2040_CR46","doi-asserted-by":"publisher","unstructured":"Mohamed MO, Kirchhof P, Vidovich M, Savage M, Rashid M, Kwok CS, \u2026 Mamas MA. Effect of concomitant atrial fibrillation on in-hospital outcomes of non-ST-elevation-acute coronary syndrome-related hospitalizations in the United States.\u00a0 Am J Cardiol. 2019;124(4):465\u2013475.\u00a0https:\/\/doi.org\/10.1016\/j.amjcard.2019.05.040.","DOI":"10.1016\/j.amjcard.2019.05.040"},{"key":"2040_CR47","doi-asserted-by":"publisher","unstructured":"Fernandes GC, Kovacs R, Abbott JD, Subacius H, Dyal MD, Goldberger JJ, Outcomes of Beta-Blocker Therapy After Myocardial Infarction (OBTAIN) Investigators. Determinants of early and late in-hospital mortality after acute myocardial infarction: A subanalysis of the OBTAIN registry. Can J Cardiol. 2023;39(4):531\u2013537.\u00a0https:\/\/doi.org\/10.1016\/j.cjca.2022.10.019.","DOI":"10.1016\/j.cjca.2022.10.019"},{"issue":"9","key":"2040_CR48","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/eurheartj\/ehn579","volume":"30","author":"J Schmitt","year":"2009","unstructured":"Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30(9):1038\u201345.\u00a0https:\/\/doi.org\/10.1093\/eurheartj\/ehn579.","journal-title":"Eur Heart J"},{"issue":"1","key":"2040_CR49","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1378\/chest.06-2733","volume":"132","author":"C-W Siu","year":"2007","unstructured":"Siu C-W, Jim M-H, Ho H-H, Miu R, Lee SWL, Lau C-P, Tse H-F. Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke. Chest. 2007;132(1):44\u20139.\u00a0https:\/\/doi.org\/10.1378\/chest.06-2733.","journal-title":"Chest"},{"issue":"5","key":"2040_CR50","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1160\/TH11-05-0343","volume":"106","author":"R Bishara","year":"2011","unstructured":"Bishara R, Telman G, Bahouth F, Lessick J, Aronson D. Transient atrial fibrillation and risk of stroke after acute myocardial infarction. Thromb Haemost. 2011;106(5):877\u201384.\u00a0https:\/\/doi.org\/10.1160\/TH11-05-0343.","journal-title":"Thromb Haemost"},{"key":"2040_CR51","doi-asserted-by":"publisher","unstructured":"Lee JH, Kim S-H, Lee W, Cho Y, Kang S-H, Park JJ, \u2026 Choi D-J. New-onset paroxysmal atrial fibrillation in acute myocardial infarction: increased risk of stroke. BMJ Open, 2020;10(9): e039600.\u00a0https:\/\/doi.org\/10.1136\/bmjopen-2020-039600.","DOI":"10.1136\/bmjopen-2020-039600"},{"issue":"18","key":"2040_CR52","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.108.821306","volume":"119","author":"E Anter","year":"2009","unstructured":"Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation. 2009;119(18):2516\u201325.\u00a0https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.821306.","journal-title":"Circulation"},{"key":"2040_CR53","doi-asserted-by":"publisher","unstructured":"K\u00f8ber L, Swedberg K, McMurray JJV, Pfeffer MA, Velazquez EJ, Diaz R, \u2026 Califf RM. Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. Eur\u00a0 J Heart Failure 2006;8(6):591\u2013598.\u00a0https:\/\/doi.org\/10.1016\/j.ejheart.2005.11.007.","DOI":"10.1016\/j.ejheart.2005.11.007"},{"issue":"10","key":"2040_CR54","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1093\/ehjacc\/zuab091","volume":"10","author":"P Buchta","year":"2021","unstructured":"Buchta P, Kalarus Z, Mizia-Stec K, Myrda K, Skrzypek M, Ga Sior M. De novo and pre-existing atrial fibrillation in acute coronary syndromes: impact on prognosis and cardiovascular events in long-term follow-up. Eur Heart J Acute Cardiovasc Care. 2021;10(10):1129\u201339.\u00a0https:\/\/doi.org\/10.1093\/ehjacc\/zuab091.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"2","key":"2040_CR55","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/europace\/euaa234","volume":"23","author":"J Luo","year":"2021","unstructured":"Luo J, Xu S, Li H, Gong M, Li Z, Liu B, ... Wei Y. Long-term impact of the burden of new-onset atrial fibrillation in patients with acute myocardial infarction: results from the NOAFCAMI-SH registry. EP Europace. 2021;23(2):196\u2013204. https:\/\/doi.org\/10.1093\/europace\/euaa234.","journal-title":"EP Europace."},{"key":"2040_CR56","doi-asserted-by":"publisher","unstructured":"Stamboul K, Zeller M, Fauchier L, Gudjoncik A, Buffet P, Garnier F, \u2026 Cottin Y. Prognosis of silent atrial fibrillation after acute myocardial infarction at 1-year follow-up. Heart (British Cardiac Soc), 2015;101(11):864\u2013869.\u00a0https:\/\/doi.org\/10.1136\/heartjnl-2014-307253.","DOI":"10.1136\/heartjnl-2014-307253"},{"key":"2040_CR57","doi-asserted-by":"publisher","unstructured":"Feistritzer H-J, Desch S, Zeymer U, Fuernau G, de Waha-Thiele S, Dudek D, \u2026 Thiele H. Prognostic impact of atrial fibrillation in acute myocardial infarction and Cardiogenic Shock. Cir Cardiovasc Interv. 2019;12(6):e007661.\u00a0https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.118.007661.","DOI":"10.1161\/CIRCINTERVENTIONS.118.007661"},{"key":"2040_CR58","doi-asserted-by":"publisher","unstructured":"de Waha S, Schoene K, Fuernau G, Desch S, Eitel I, P\u00f6ss J, \u2026 Thiele H. Prognostic impact of atrial fibrillation in cardiogenic shock complicating acute myocardial infarction: a substudy of the IABP-SHOCK II trial. Clin Res Cardiol: Official J German Cardiac Soc. 2018;107(3);233\u2013240.\u00a0https:\/\/doi.org\/10.1007\/s00392-017-1175-1.","DOI":"10.1007\/s00392-017-1175-1"},{"key":"2040_CR59","doi-asserted-by":"publisher","unstructured":"Lopes RD, Elliott LE, White HD, Hochman, JS, Van de Werf F, Ardissino D, \u2026 Granger CB. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur Heart J. 2009;30(16):2019\u20132028.\u00a0https:\/\/doi.org\/10.1093\/eurheartj\/ehp213","DOI":"10.1093\/eurheartj\/ehp213"},{"key":"2040_CR60","doi-asserted-by":"publisher","unstructured":"Rene AG, G\u00e9n\u00e9reux P, Ezekowitz M, Kirtane AJ, Xu K, Mehran R, \u2026 Stone GW. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial). Am J Cardiol. 2014;113(2):236\u2013242.\u00a0https:\/\/doi.org\/10.1016\/j.amjcard.2013.09.016.","DOI":"10.1016\/j.amjcard.2013.09.016"},{"key":"2040_CR61","doi-asserted-by":"publisher","unstructured":"Gibson CM, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, \u2026 Fox KA. Prevention of bleeding in patients with atrial fibrillation undergoing PCI. New Eng J Med. 2016;375(25):2423\u20132434.\u00a0https:\/\/doi.org\/10.1056\/nejmoa1611594.","DOI":"10.1056\/nejmoa1611594"},{"key":"2040_CR62","doi-asserted-by":"publisher","unstructured":"Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, \u2026 Hohnloser SH. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. New Eng J Med. 2017;377(16):1513\u20131524.\u00a0https:\/\/doi.org\/10.1056\/nejmoa1708454.","DOI":"10.1056\/nejmoa1708454"},{"key":"2040_CR63","doi-asserted-by":"publisher","unstructured":"Lopes RD, Heizer G, Aronson R, Vora AN, Massaro T, Mehran R, \u2026 AUGUSTUS Investigators. Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation.\u00a0 New Eng J Med. 2019;380(16):1509\u20131524.https:\/\/doi.org\/10.1056\/NEJMoa1817083.","DOI":"10.1056\/NEJMoa1817083"},{"key":"2040_CR64","doi-asserted-by":"publisher","unstructured":"Vranckx P, Valgimigli M, Eckardt L, Tijssen J, Lewalter T, Gargiulo G, \u2026 Goette A. Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial. Lancet. 2019;394(10206):1335\u20131343.\u00a0https:\/\/doi.org\/10.1016\/S01406736(19)31872-0.","DOI":"10.1016\/S01406736(19)31872-0"},{"key":"2040_CR65","doi-asserted-by":"publisher","unstructured":"January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, \u2026 Yancy CW. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: A report of the American college of cardiology\/American heart association task force on clinical practice guidelines and the heart rhythm society in collaboration with the society of thoracic surgeons. Circulation. 2019;140(2):e125\u2013e151.\u00a0https:\/\/doi.org\/10.1161\/CIR.0000000000000665.","DOI":"10.1161\/CIR.0000000000000665"},{"key":"2040_CR66","doi-asserted-by":"publisher","unstructured":"Lopes RD, Hong H, Harskamp RE, Bhatt DL, Mehran R, Cannon CP, \u2026 Alexander JH. Safety and efficacy of antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: A network meta-analysis of randomized controlled trials. JAMA Cardiol. 2019;4(8):747\u2013755.\u00a0https:\/\/doi.org\/10.1001\/jamacardio.2019.1880.","DOI":"10.1001\/jamacardio.2019.1880"},{"issue":"1","key":"2040_CR67","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ahj.2015.03.019","volume":"170","author":"Mathews, R., Wang, T. Y., Honeycutt, E., Henry, T. D., Zettler, M., Chang, M., \u2026 TRANSLATE-ACS Study Investigators","year":"2015","unstructured":"Mathews, R., Wang, T. Y., Honeycutt, E., Henry, T. D., Zettler, M., Chang, M., \u2026 TRANSLATE-ACS Study Investigators. Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study. Am Heart J. 2015;170(1):62\u20139. https:\/\/doi.org\/10.1016\/j.ahj.2015.03.019.","journal-title":"Am Heart J"},{"key":"2040_CR68","doi-asserted-by":"publisher","unstructured":"De Luca L, Rubboli A, Bolognese L, Uguccioni M, Lucci D, Blengino S, \u2026 MATADOR-PCI Investigators. Is percutaneous coronary intervention safe during uninterrupted direct oral anticoagulant therapy in patients with atrial fibrillation and acute coronary syndromes? Open Heart. 2021;8(2):e001677. \nhttps:\/\/doi.org\/10.1136\/openhrt-2021-001677.","DOI":"10.1136\/openhrt-2021-001677"},{"key":"2040_CR69","doi-asserted-by":"publisher","unstructured":"McMurray J, K\u00f8ber L, Robertson M, Dargie H, Colucci W, Lopez-Sendon J, \u2026 Ford I. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll Cardiol. 2005;45(4):525\u2013530. \nhttps:\/\/doi.org\/10.1016\/j.jacc.2004.09.076.","DOI":"10.1016\/j.jacc.2004.09.076"},{"issue":"4","key":"2040_CR70","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1161\/01.cir.100.4.376","volume":"100","author":"OD Pedersen","year":"1999","unstructured":"Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation. 1999;100(4):376\u201380. https:\/\/doi.org\/10.1161\/01.cir.100.4.376.","journal-title":"Circulation"},{"issue":"4","key":"2040_CR71","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1136\/heart.88.4.357","volume":"88","author":"C-K Wong","year":"2002","unstructured":"Wong C-K. Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Br Heart J. 2002;88(4):357\u201362. https:\/\/doi.org\/10.1136\/heart.88.4.357.","journal-title":"Br Heart J"},{"key":"2040_CR72","doi-asserted-by":"publisher","unstructured":"Nilsson KR Jr, Al-Khatib SM, Zhou Y, Pieper K, White HD, Maggioni AP, \u2026 Velazquez EJ. Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial. Heart (British Cardiac Soc). 2010;96(11):838\u2013842. \nhttps:\/\/doi.org\/10.1136\/hrt.2009.180182.","DOI":"10.1136\/hrt.2009.180182"},{"key":"2040_CR73","doi-asserted-by":"publisher","unstructured":"Danchin N, Fauchier L, Marijon E, Barnay C, Furber A, Mabo P, \u2026 French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) Investigators. Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: data from the FAST-MI register. Heart (British Cardiac Soc), 2010;96(22):1809\u20131814. \nhttps:\/\/doi.org\/10.1136\/hrt.2010.201574.","DOI":"10.1136\/hrt.2010.201574"},{"issue":"3","key":"2040_CR74","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1177\/2047487312462804","volume":"21","author":"CN Bang","year":"2014","unstructured":"Bang CN, Gislason GH, Greve AM, Torp-Pedersen C, K\u00f8ber L, Wachtell K. Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study. Eur J Prev Cardiol. 2014;21(3):330\u20138. https:\/\/doi.org\/10.1177\/2047487312462804.","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"2040_CR75","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.amjcard.2007.03.034","volume":"100","author":"G Ramani","year":"2007","unstructured":"Ramani G, Zahid M, Good CB, Macioce A, Sonel AF. Comparison of frequency of new-onset atrial fibrillation or flutter in patients on statins versus not on statins presenting with suspected acute coronary syndrome. Am J Cardiol. 2007;100(3):404\u20135. https:\/\/doi.org\/10.1016\/j.amjcard.2007.03.034.","journal-title":"Am J Cardiol"},{"issue":"1","key":"2040_CR76","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/europace\/euu217","volume":"17","author":"BM Scirica","year":"2015","unstructured":"Scirica BM, Belardinelli L, Chaitman BR, Waks JW, Volo S, Karwatowska-Prokopczuk E, ... Morrow DA. Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial. EP Europace. 2015;17(1):32\u20137. https:\/\/doi.org\/10.1093\/europace\/euu217.","journal-title":"EP Europace."},{"key":"2040_CR77","doi-asserted-by":"publisher","unstructured":"Kundu A, O\u2019Day K, Shaikh AY, Lessard DM, Saczynski JS, Yarzebski J, \u2026 McManus DD. Relation of atrial fibrillation in acute myocardial infarction to in-hospital complications and early hospital readmission. Am J Cardiol. 2016;117(8):1213\u20131218.\u00a0https:\/\/doi.org\/10.1016\/j.amjcard.2016.01.012.","DOI":"10.1016\/j.amjcard.2016.01.012"},{"key":"2040_CR78","doi-asserted-by":"publisher","unstructured":"Mohamed Ibrahim I, Taha Hassanin M, El Zaki MM. Tissue Doppler-derived atrial dyssynchrony predicts new-onset atrial fibrillation during hospitalization for ST-elevation myocardial infarction. Echocardiography (Mount Kisco, N.Y.) 2019;36(10);1799\u20131805.\u00a0https:\/\/doi.org\/10.1111\/echo.14486.","DOI":"10.1111\/echo.14486"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02040-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-024-02040-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02040-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T09:15:55Z","timestamp":1716974155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-024-02040-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["2040"],"URL":"https:\/\/doi.org\/10.1007\/s11886-024-02040-7","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,14]]},"assertion":[{"value":"4 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Muhie Sabayon reports consulting fees from Biosense Webster and Boston Scientific, and speaker fees from Abbott and Boston Scientific. The other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}